LabVantage Unveils 90 Day/$90K* Guaranteed Implementation for its SAPPHIRE BioBanking Solution
Bridgewater, NJ. November 13, 2008. LabVantage today introduced the 90 day/$90K* guaranteed implementation for its SAPPHIRE BioBanking Solution. Already well recognized as the premier enterprise solution for biospecimen management, the full-featured, out-of-the-box SAPPHIRE BioBanking Solution is now guaranteed to be delivered by LabVantage within a fixed duration of 90 days and at a fixed cost of $90,000.*
“Magnified by today’s economic climate, there are unprecedented pressures for organizations to quickly meet business objectives and maximize the return on investment for their IT [information technology] projects,” explains Ron Kasner, VP of Corporate Development of LabVantage. “By coupling our industry leading solution with a guaranteed implementation from our world-class professional services organization, LabVantage has eliminated the risks associated with system implementation with no compromise on quality.”
LabVantage has received awards for its biobanking software innovation and customer services leadership by a leading market research & consulting firm. It has also garnered a vast customer base for its SAPPHIRE BioBanking Solution, ranging from foremost scientific research institutes to dominant contract research organizations, and from fast growing biotechnology companies to global pharmaceutical enterprises.
LabVantage’s guaranteed implementation serves the needs of both large and small organizations. For small-to-medium sized biobanking projects, it addresses the comprehensive requirements for biospecimen management in a timely and standardized fashion. At the same time, for complex biobanking projects, it is a robust foundation for enterprises to demonstrate quick success from rapid deployment.
A part of the SAPPHIRE Laboratory Information Management Suite (LIMS), a zero-footprint configurable-off-the-shelf (COTS) solution, the SAPPHIRE BioBanking Solution provides a centralized solution for the storage, data capture, retrieval, and processing of biospecimens throughout an organization. It addresses the need for study management, package tracking & handling, sample management, storage & inventory management, and analytics & reporting. Developed specifically for biorepositories and in collaboration with industry organizations, it has also received the caBIG (cancer Biomedical Informatics Grid) Bronze Compatibility Certification by National Cancer Institute Center for Bioinformatics (NCICB).
“LabVantage is the first and only biobanking solution provider to deliver this guaranteed offer,” affirms Jim Aurelio, President & CEO of LabVantage. “To date, LabVantage has been the partner-of-choice for organizations needing to standardize their laboratory and biobanking informatics. Now, with the zero-risk option of our guaranteed implementation, we have made the decision to select LabVantage and SAPPHIRE even easier.”
More information about the SAPPHIRE BioBanking Solution and LabVantage’s Guaranteed Implementation is available at http://www.labvantage.com/zerorisk/pr/gbb.html.
About LabVantage. LabVantage Solutions, Inc., an innovative global provider of enterprise solutions tailored for leading laboratories, serves discovery, development, formulation, process research, raw material testing, and quality management laboratories across multiple industries. LabVantage’s SAPPHIRE, a zero-footprint laboratory information management suite, is tailored to manage an organization’s critical laboratory information across its worldwide operations to optimize productivity and more effectively share knowledge. LabVantage is headquartered in Bridgewater, NJ, U.S.A. Further information about LabVantage and SAPPHIRE is available at www.labvantage.com.
LabVantage, SAPPHIRE, and their respective logos are trademarks or registered trademarks of LabVantage Solutions, Inc. in the U.S and other countries around the world. All other product and service names mentioned are the trademarks of their respective companies.
*Please contact LabVantage for non-US pricing.
